# In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)

> **NCT04370977** · PHASE4 · COMPLETED · sponsor: **Centro de Investigacao em Saude de Manhica** · enrollment: 630 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Coartem™ (Artemether-lumefantrine combination)
- **DRUG:** Winthrop™ (Amodiaquine-artesunate combination)

## Key facts

- **NCT ID:** NCT04370977
- **Lead sponsor:** Centro de Investigacao em Saude de Manhica
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-21
- **Primary completion:** 2018-09-29
- **Final completion:** 2019-12-19
- **Target enrollment:** 630 (ACTUAL)
- **Last updated:** 2020-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370977, "In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04370977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*